Disease ProgressionHepatitis BHepatitis CHepatitis AHepatitis B virusHepatitis B Surface AntigensHepatitisHepatitis C, ChronicHepatitis B, ChronicHepatitis, Viral, HumanHepatitis A virusHepatitis B VaccinesHepatitis B AntibodiesHepatitis, ChronicHepacivirusHepatitis B Core AntigensHepatitis A VaccinesHepatitis AntibodiesHepatitis B e AntigensHepatitis B AntigensHepatitis EHepatitis C AntibodiesHepatitis E virusHepatitis A AntibodiesHepatitis, AutoimmuneHepatitis, Viral, AnimalHepatitis A Virus, HumanHepatitis VirusesHepatitis Delta VirusHepatitis DHepatitis, AnimalAntiviral AgentsViral Hepatitis VaccinesRNA, ViralLiver CirrhosisHIV InfectionsMurine hepatitis virusViral LoadInterferon-alphaTreatment OutcomeHepatitis C AntigensHepatovirusTime FactorsCarcinoma, HepatocellularLiver NeoplasmsRibavirinHepatitis A AntigensGenotypeHepatitis delta AntigensDNA, ViralLiverHepatitis AntigensMolecular Sequence DataHepatitis, AlcoholicAlanine TransaminasePrognosisHepatitis B Virus, DuckHIV-1Disease Models, AnimalVirus ReplicationCD4 Lymphocyte CountViral Nonstructural ProteinsFollow-Up StudiesBiological MarkersHepatitis B Virus, WoodchuckRisk FactorsMutationCell Line, TumorBase SequenceRetrospective StudiesPolyethylene GlycolsCohort StudiesSurvival AnalysisLamivudineProspective StudiesPolymerase Chain ReactionImmunohistochemistryViral Core ProteinsRecombinant ProteinsLiver TransplantationNeoplasm MetastasisChronic DiseaseHepatitis D, ChronicCell LineDrug Therapy, CombinationProstatic NeoplasmsAcquired Immunodeficiency SyndromeCell CycleMice, TransgenicSeverity of Illness IndexMarmotaReverse Transcriptase Polymerase Chain ReactionRecurrenceAmino Acid SequenceBiopsyAntineoplastic AgentsDisease-Free SurvivalSeroepidemiologic StudiesTumor Markers, BiologicalHepatocytes